But the three-judge panel declined to disturb their other convictions for conspiring to violate the Controlled Substances Act, commit racketeering and accept kickbacks from a bankrupt opioid drug manufacturer, Insys Therapeutics Inc. Prosecutors must now decide whether to retry Ruan and Couch or move straight to resentencing on their remaining convictions.